iifl-logo

Zydus Lifesciences Ltd Historical Data

878.65
(0.57%)
May 9, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Zydus Lifesciences Ltd Historical Data

09/04/2025calendar-icon
09/05/2025calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

09-Apr-2025

840.4

849.85823.3844.451,6811,34,04,25,897.358,44,119

11-Apr-2025

863.85

879855.2868.8531,52596,54,75,370.155,92,373

15-Apr-2025

889.8

889.8868.6883.1540,7471,36,11,35,526.29,19,034

16-Apr-2025

883.15

887.25813822.11,87,3968,57,38,31,83646,97,293

17-Apr-2025

830

839.15816.1831.551,38,2863,38,89,40,457.416,77,469

21-Apr-2025

832.35

847830.25845.3541,6461,55,91,12,575.810,37,235

22-Apr-2025

845.35

854.2837.9852.735,75386,15,11,568.954,59,828

23-Apr-2025

857.6

873852.786843,37599,25,40,676.754,95,198

24-Apr-2025

868

887.25861.5880.2538,5111,02,62,46,894.14,98,564

25-Apr-2025

879.65

882.35858859.6539,56894,14,75,240.355,61,860

28-Apr-2025

862.95

887.7861.25886.5545,8911,34,53,88,306.39,41,859

29-Apr-2025

887

894.85877.05888.0528,74991,20,22,310.255,53,531

30-Apr-2025

888

901.85883888.2530,35780,94,89,265.95,00,983

02-May-2025

887

893.4874.9885.644,98471,02,96,548.83,51,190

05-May-2025

885.6

895880.05892.516,83834,96,62,144.61,97,892

06-May-2025

886

886869.15880.6523,36088,17,17,157.155,25,544

07-May-2025

863.2

889.15863.2886.1527,66872,25,56,084.84,38,037

08-May-2025

886

888.85865.5873.723,51081,32,75,014.755,52,289

Zydus Lifesci.: Related NEWS

Zydus Wins USFDA Approval for Cholesterol Drug
30 Apr 2025|11:25 PM

The medication is also prescribed to lower the risk of another heart attack in individuals with a past history of myocardial infarction and hyperlipidaemia

Read More
Zydus Lifesciences Gets USFDA Nod for Niacin ER Tablets in Multiple Strengths
30 Apr 2025|03:28 PM

USFDA's final approval is available for Zydus Lifesciences and group companies, and this will allow the group to sell the product in the highly regulated US market.

Read More
Zydus Gets USFDA Nod for Jaythari Tablets
16 Apr 2025|10:54 AM

The approval includes various strengths of Jaythari, 6 mg, 18 mg, 30 mg, and 36 mg, which adds to Zydus' portfolio of products in the US generic pharma market.

Read More
Zydus Lifesciences sets up new unit in France
15 Apr 2025|08:58 AM

As per the company’s filing, this new subsidiary will be the vehicle through which Zydus plans to acquire the equity shares of Amplitude Surgical SA.

Read More
Top Stocks for Today - 15th April 2025
15 Apr 2025|06:15 AM

Here are some of the stocks that may see significant price movement today: GAIL, Zydus Lifesciences, Aurobindo Pharma, etc.

Read More
Zydus Lifesciences gets USFDA approval for apalutamide tablets
19 Mar 2025|11:30 AM

As per the IQVIA MAT January 2025 data, apalutamide tablets registered annual sales of $1099.80 million in the United States markets.

Read More
Top Stocks for Today - 19th March 2025
18 Mar 2025|11:57 PM

Here are some of the stocks that may see significant price movement today: Bajaj Auto, NTPC, GR Infraprojects, etc.

Read More
Top Stocks for Today - 17th March 2025
17 Mar 2025|07:01 AM

Here are some of the stocks that may see significant price movement today: Dalmia Bharat, Galaxy Surfactants, Tata Motors, etc.

Read More
Zydus Lifesciences' Gujarat Unit Clears USFDA Inspection
16 Mar 2025|09:28 PM

The inspection concluded with “NIL observations,” the firm said in a regulatory filing, underlining its strong compliance with quality and manufacturing practices.

Read More
Zydus Lifesciences to Acquire 100% Stake in Amplitude Surgical for €300 Million
13 Mar 2025|11:27 AM

The deal is subject to signing a put option agreement, share purchase agreements and other relevant contracts for acquisition of controlling shareholding of Amplitude Surgical SA, directly or through Zydus' affiliates.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.